West Pharmaceutical Services, Inc.WSTNYSE
Loading
R&D Expense Growth TrendStable
Percentile Rank43
3Y CAGR-11.3%
5Y CAGR-18.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-11.3%/yr
vs +36.9%/yr prior
5Y CAGR
-18.2%/yr
Recent acceleration
Acceleration
-48.3pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 7.53% |
| 2024 | 1.02% |
| 2023 | 16.92% |
| 2022 | 10.80% |
| 2021 | 12.58% |
| 2020 | 20.57% |
| 2019 | -3.47% |
| 2018 | 3.07% |
| 2017 | 6.25% |
| 2016 | 7.92% |